Pr Michael Edelstein

Bar Ilan U.: Vaccines dramatically reduce the risk of long-term effects of COVID-19

Being vaccinated with at least two doses of Pfizer vaccines dramatically reduces most of the long-term symptoms individuals reported months after contracting COVID-19, a...

Read more
Pr Michael Edelstein

Bar-Ilan University/Ziv Medical Center: 2nd vaccine dose needed for individuals infected with COVID-19 shortly after the first dose

A second dose of the COVID-19 vaccine should be offered to individuals infected with the virus shortly after receiving the first dose, according to...

Read more

Hebrew U.: Clinical Results Show Tricor (Fenofibrate) effective In Treating Severe Covid-19 Patients

The SARS-CoV-2 virus has infected over 165 million people worldwide causing nearly 3.5 million deaths. Recent vaccination efforts have been hindered by multiple coronavirus...

Read more
Professor Ronen Leker at Hebrew U. Hadassah

Hebrew U.: Large-Scale Study Finds Strong Connection Between Corona and Strokes – Particularly in Younger Patients

Ever since the coronavirus became a wide-spread global pandemic, medical researchers have sought to understand how the virus impacts other medical ailments, especially neurological...

Read more

UK Clinical Trial Confirms SaNOtize’s (Israel) Breakthrough Treatment for COVID-19

Biotech company SaNOtize R&D Corp., Ashford and St Peter’s Hospitals NHS Foundation Trust in Surrey, UK, and Berkshire and Surrey Pathology Services, UK, today...

Read more

(Français) COVID-19 : Oramed Pharmaceuticals met au point un vaccin par prise orale “idéal contre les variants”

Sorry, this entry is only available in French. For the sake of viewer convenience, the content is shown below in the alternative language. You...

Read more
Dr Gilly Regev

Israel – New-Zealand : approval to sell its Nitric Oxide Nasal Spray which protects users from viruses

Biotech company SaNOtize Research & Development Corp., (SaNOtize) today announced that it has received interim approval to sell its Nitric Oxide Nasal Spray (NONS),...

Read more
Pr Michael Edelstein

(Français) Bar-Ilan U. et Ziv Center : forte réponse immunitaire avec 1 dose de vaccin Covid-19 chez des personnes précédemment infectées

Although clinical trial data are encouraging, real-world evidence with regard to the COVID-19 vaccine remains scarce. In particular, response to the vaccine among those...

Read more

Israël Science Info